Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against β-amyloid toxicity-Reference-Cited by-同舟云学术

Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against β-amyloid toxicity

Published:2005-06 Issue:1 Volume:1047 Page:30-37
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Caraci Filippo,Chisari Mariangela,Frasca Giuseppina,Canonico Pier Luigi,Battaglia Angelo,Calafiore Marco,Battaglia Giuseppe,Bosco Paolo,Nicoletti Ferdinando,Copani Agata,Sortino Maria Angela

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference40 articles.

1. Studies on the metabolism of ergoline derivatives. Metabolism of nicergoline in man and in animals;Arcamone;Biochem. Pharmacol.,1972

2. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation;Barger;Proc. Natl. Acad. Sci. U. S. A.,1995

3. Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicity;Battaglia;J. Neurochem.,2003

4. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta;Bruno;J. Neurosci.,1998

5. Pharmacological basis for the clinical effects of nicergoline in dementia;Canonico;Geriatria,1998

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cognitive Impairment and Nootropic Drugs: Mechanism of Action and Spectrum of Effects;Neurochemical Journal;2023-06

2. Cognitive Impairment and Nootropic Drugs: Mechanism of Action and Spectrum of Effects;Нейрохимия;2023-04-01

3. NOOTROPICS: A LONG WAY IN HALF A CENTURY;Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії;2023-03-13

4. Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs;Nutrients;2022-08-17

5. Therapeutics targeting BCL2 family proteins;Mechanisms of Cell Death and Opportunities for Therapeutic Development;2022